Pfizer Inc (NYSE:PFE)

41.99
Delayed Data
As of 4:02pm ET
 +0.32 / +0.77%
Today’s Change
35.32
Today|||52-Week Range
46.47
-3.80%
Year-to-Date
Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint
May 21 / Zacks.comZAK - Paid Partner Content
Better Buy: Eli Lilly vs. Pfizer
May 19 / MotleyFool.comFOO - Paid Partner Content
IMS Capital Management Buys JPMorgan Ultra-Short Income, Vistra Energy Corp, Invesco ...
May 21 / GuruFocus NewsGURU - Paid Partner Content
Where Will Pfizer Be in 5 Years?
May 18 / MotleyFool.comFOO - Paid Partner Content
GYL Financial Synergies, LLC Buys iShares Core S&P Small-Cap, Schwab U.S. ...
May 21 / GuruFocus NewsGURU - Paid Partner Content
Dow 30 Stock Roundup: Walmart, Cisco Earnings Impress
May 17 / Zacks.comZAK - Paid Partner Content
Merck's Keytruda Fails in Late-Stage Breast Cancer Study
May 21 / Zacks.comZAK - Paid Partner Content
Laurel Wealth Advisors, Inc. Buys Pfizer Inc, Avista Corp, SPDR S&P 500, Sells iShare...
May 16 / GuruFocus NewsGURU - Paid Partner Content
Better Buy: AbbVie vs. Pfizer
May 21 / MotleyFool.comFOO - Paid Partner Content
Pfizer's Eczema Candidate Meets All Goals in Phase III Study
May 16 / Zacks.comZAK - Paid Partner Content

Today’s Trading

Previous close41.67
Today’s open41.69
Day’s range41.55 - 42.21
Volume23,979,686
Average volume (3 months)24,363,377
Market cap$230.5B
Data as of 4:02pm ET, 05/22/2019

Growth & Valuation

Earnings growth (last year)-46.78%
Earnings growth (this year)-3.70%
Earnings growth (next 5 years)+3.74%
Revenue growth (last year)+2.10%
P/E ratio21.5
Price/Sales4.86
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
MRKMerck+1.48+1.86%
NVSNovartis+1.52+1.84%
ABTAbbott Laboratories+0.23+0.30%
ABBVAbbVie+0.71+0.88%
Data as of 4:02pm ET, 05/22/2019

Financials

Next reporting dateJuly 30, 2019
EPS forecast (this quarter)$0.74
Annual revenue (last year)$53.6B
Annual profit (last year)$11.2B
Net profit margin20.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Director, Chief Executive &
Operating Officer
Albert Bourla
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts